arrow
V

Velma Ganga Reddy

University of Arizona
H指数:19
被引数:1,386

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mixed Lineage Kinase Suppression in Triple-Negative Breast Cancer: Identification of a Dual Inhibitor Targeting MLK3 and NAMPT

三阴性乳腺癌中混合谱系激酶的抑制:鉴定靶向MLK3和NAMPT的双靶点抑制剂

2026-06-100
PRE
(E)-4-(4-Acrylamidophenoxy)-N-Methylpicolinamides as b-Raf/VEGFR-2 Inhibitors with Antiangiogenic Activity in HUVEC and Zebrafish Model

(E)-4-(4-丙烯酰胺苯氧基)-N-甲基吡啶酰胺作为b-Raf/VEGFR-2抑制剂,在HUVEC和斑马鱼模型中具有抗血管生成活性

2026-05-210
OA
Discovery of the SARS-CoV-2 Papain-Like Protease Inhibitor MR1–114: From Structure-Based Design to In Vivo Antiviral Efficacy

SARS-CoV-2半胱氨酸蛋白酶抑制剂MR1–114的发现:从基于结构的药物设计到体内抗病毒功效

2026-03-260
OA
Gold(I) somplexes of the type [AuL{κC-2-C6H4P(S)Ph2}] [L = PTA, PPh3, PPh2(C6H4-3-SO3Na) and PPh2(2-py)]: Synthesis, characterisation, crystal structures, and In Vitro and In Vivo anticancer properties
2025-01-010
PRE
Non-Covalent Inhibitors of SARS-CoV-2 Papain-Like Protease (PLpro): In Vitro and In Vivo Antiviral Activity

SARS-CoV-2木瓜蛋白酶样蛋白酶 (PLpro) 的非共价抑制剂: 体外和体内抗病毒活性

2024-08-051
OAAI
Synthesis and in vitro cytotoxicity evaluation of β-carboline-combretastatin carboxamides as apoptosis inducing agents: DNA intercalation and topoisomerase-II inhibition

Β-咔啉-combrestatin羧酰胺作为凋亡诱导剂的合成和体外细胞毒性评估: DNA嵌入和拓扑异构酶-II抑制

2019-08-0142
PREAI